Dishman Carbogen Amcis Reports Strong Financial Performance in Q2 FY25

Dishman Carbogen Amcis, a smallcap pharmaceutical company, has recently announced its financial results for the quarter ending September 2024. The company has shown a positive performance in the second quarter of the fiscal year 2024-25, with a score of 10, a significant improvement from -20 in the previous three months.

The company’s Profit Before Tax less Other Income (PBT) for the quarter has grown by 192.20% Year on Year (YoY) to Rs 38.43 crore. The Profit After Tax (PAT) has also shown a growth of 193.6% YoY to Rs 35.42 crore. This indicates a very positive trend in the near term for the company’s profitability.

Dishman Carbogen’s Operating Profit to Interest ratio for the quarter is at its highest in the last five quarters, standing at 4.02 times. This shows an improvement in the company’s ability to manage its interest payments. The Operating Cash Flow for the year has also been the highest in the last three years at Rs 383.97 crore, indicating a strong cash flow from the company’s business operations.

The company’s Net Sales for the quarter have also shown a positive trend, with a growth of 34.51% YoY to Rs 789.04 crore. The Operating Profit (PBDIT) for the quarter is at its highest in the last five quarters at Rs 147.15 crore, and the Operating Profit Margin is also at its highest in the last five quarters at 18.65%. This indicates an improvement in the company’s efficiency.

Dishman Carbogen’s Debt-Equity Ratio has been increasing each half year in the last five periods, reaching its highest at 0.44 times. This shows that the company is borrowing more to fund its operations, which may lead to a stressed liquidity situation. The Interest cost for the quarter has also increased by 14.72% Quarter on Quarter (QoQ) to Rs 36.63 crore, indicating a rise in borrowings.

The company’s Debtors Turnover Ratio for the half year is at its lowest in the last five periods at 3.71 times, showing a slowdown in the pace of settling its Debtors. However, the company’s Earnings per Share (EPS) for the quarter is at its highest in the last five quarters at Rs 2.11, indicating an increase in profitability and creating higher earnings for shareholders.

Overall, Dishman Carbogen Amcis has shown a positive financial performance in the second quarter of the fiscal year 2024-25, with a strong growth in key financial indicators. However, the company’s increasing Debt-Equity Ratio and Interest cost may be a cause for concern and should be closely monitored.